Our results are also consistent with the finding of elevated betatrophin in patients with obesity and type 2 diabetes [9, 13–18], however unchanged [19] or even decreased [20] serum betatrophin levels have been reported in diabetic or/and insulin resistant patients as well. This evidence concerns the gene INS and Obesity.